Learn about emerging treatments for metastatic liver cancer. We’ve got it covered, from new FDA approvals to emerging approaches in targeted therapy, immunotherapy, ablation, surgery, modified viruses, and more.

  • August 5, 2022  

    Recent Advances in Systemic Therapy for Hepatocellular Carcinoma Bookmark

    George Lundberg, MD

    This review article in the academic research journal Biomarker Research discusses how combining immunotherapy and targeted therapies provides new hope for people with hepatocellular carcinoma.

    .

  • August 5, 2022  

    Treatment Approaches for Advanced Hepatocellular Carcinoma: Insight From the 2022 Gastrointestinal Cancers Symposium Bookmark

    George Lundberg, MD

    In this article for Cancer Therapy Advisor, Dr. Shaalan Beg shares updates from the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium on treatments for advanced hepatocellular carcinoma.

    .

    • SEE ALL
My family is so grateful for the information and guidance we received from Cancer Commons during a particularly stressful time where a decision needed to be made quickly. We are particularly thankful for the help and assistance of Matthew Warner…It helped give us confirmation that the trial we were looking at for my dad’s recurrent GBM was a reasonable and good decision.

Megan
Daughter of Glioblastoma patient

Molecular tests help match patients to the personalized treatments that are most likely to work for them. Keep up with new developments in molecular testing that could help guide liver cancer treatment, such as detection of genetic mutations and other biomarkers.

Some of the most promising new treatments for metastatic liver cancer are currently being tested in patients enrolled in clinical trials. We help you stay up to date on the latest results from these studies.

  • January 29, 2021  

    Efficacy and Safety of Sorafenib Plus Vitamin K Treatment for Hepatocellular CarcinomA: A Phase II, Randomized Study Bookmark

    George Lundberg, MD

    This scientific research paper published in the journal Cancer Medicine reports that the drug sorafenib has shown some effectiveness against hepatocellular carcinoma in a clinical trial, and that adding vitamin K2 enhanced that effectiveness.

    .

  • November 24, 2020  

    Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Bookmark

    George Lundberg, MD

    This academic research paper from The New England Journal of Medicine reports results from a clinical trial in which a treatment that combines the drugs atezolizumab and bevacizumab improved both progression-free and overall survival for people with unresectable primary liver cancer.

    .

    • SEE ALL
In a field as complex and dynamic as molecular oncology in 2020, Cancer Commons offers an amazing opportunity for patients with advanced cancer to obtain scientifically up-to-date additional options that may improve both the length and quality of their lives, all free of charge.

Gavin Gordon, PhD
Molecular Pathologist

Cancer affects many aspects of life, whether you’re newly diagnosed, in the midst of treatment, or in follow-up care. Learn about ways to maintain quality of life, such as palliative care and managing side effects.

  • October 14, 2019  

    Pediatric Palliative Care: A Specialty Comes of Age

    Sarah Friebert, MD

    For a child with cancer, palliative care can provide much-needed relief from stress and symptoms—for the patient and their family alike. Palliative care is given alongside cancer treatment, and is not synonymous with “end-of-life” care. In fact, anyone with a serious illness can benefit from palliative care, no matter their long-term outlook. Because of its importance for children with cancer, we are honored to… Read more »

  • August 11, 2021  

    Anxiety Before Each Chemotherapy Treatment Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Pancreatic cancer patients share their experiences with pre-chemo anxiety and their personal strategies for overcoming it.

    .

  • January 29, 2021  

    Tumour Ablation for Liver Cancer: What to Expect at Home Bookmark

    George Lundberg, MD

    Ablation therapy is becoming common practice for treatment of cancer that begins in the liver. MyHealth.Alberta.ca provides information on recovery and at-home care following the procedure.

    • SEE ALL

You’re not alone. Read how other patients and caregivers navigated diagnosis, treatment, and life with cancer. We hope their stories provide insights and hope for your own cancer journey.

More patient stories

Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.

  • November 10, 2022  

    A Powerful Knowledge Base for Precision Oncology

    With: Hongxin Zhang

    Genetic mutations found in a tumor can be important clues to the patient’s best treatment options. Memorial Sloan Kettering Cancer Center (MSK) in New York has developed a product called OncoKB™, which enables anyone to access and navigate key clinical information about the various genetic abnormalities that may be found in tumors. Here, Curious Dr. George asks MSK Lead Software Engineer Hongxin Zhang about… Read more »

  • June 2, 2022  

    Harnessing Each Patient’s Data to Help Many More

    With: Kaumudi Bhawe, PhD

    At Cancer Commons, we don’t just help people navigate cancer treatment; we learn from everyone we help. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, to share how new knowledge can be captured from every patient to help many more. Curious Dr. George: Cancer Commons has accumulated in-depth data on many hundreds of patients with various cancers. Because of the… Read more »

    • SEE ALL

The coronavirus pandemic presents unprecedented challenges to cancer patients. We can help you understand how COVID-19 might impact your treatment and other aspects of your cancer care.